Xu J - Search Results

1

Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients: A 12-week randomized placebo-controlled phase III trial with long-term extension.

Yu C, Geng S, Yang B, Deng Y, Li F, Kang X, Bi M, Zhang F, Zhao Y, Pan W, Tian Z, Xu J, Zhang Z, Yu N, Duan X, Guo S, Sun Q, Li W, Tao J, Liu Z, Yin Y, Wang G. Yu C, et al. Among authors: xu j. Chin Med J (Engl). 2024 May 20;137(10):1190-1198. doi: 10.1097/CM9.0000000000002873. Epub 2024 Jan 9. Chin Med J (Engl). 2024. PMID: 38192233 Free PMC article. Clinical Trial.

2

Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial.

Yang HZ, Wang K, Jin HZ, Gao TW, Xiao SX, Xu JH, Wang BX, Zhang FR, Li CY, Liu XM, Tu CX, Ji SZ, Shen Y, Zhu XJ. Yang HZ, et al. Chin Med J (Engl). 2012 Jun;125(11):1845-51. Chin Med J (Engl). 2012. PMID: 22884040 Clinical Trial.

3

Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.

Ma L, Yang Q, Yang H, Wang G, Zheng M, Hao F, Gu J, Sun Q, Cui P, Ge M, Li R, Gao T, Facy P, Kurvits M, Xu Z, Xu J. Ma L, et al. Among authors: xu z, xu j. Int J Dermatol. 2016 Jan;55(1):106-13. doi: 10.1111/ijd.12788. Epub 2015 Jun 20. Int J Dermatol. 2016. PMID: 26094549 Clinical Trial.

4

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis.

Liu P, Zhao Y, Mu ZL, Lu QJ, Zhang L, Yao X, Zheng M, Tang YW, Lu XX, Xia XJ, Lin YK, Li YZ, Tu CX, Yao ZR, Xu JH, Li W, Lai W, Yang HM, Xie HF, Han XP, Xie ZQ, Nong X, Guo ZP, Deng DQ, Shi TX, Zhang JZ. Liu P, et al. Chin Med J (Engl). 2016 Apr 5;129(7):757-62. doi: 10.4103/0366-6999.178960. Chin Med J (Engl). 2016. PMID: 26996468 Free PMC article.

5

Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients.

Chen K, Wang G, Jin H, Xu J, Zhu X, Zheng M, Gu H. Chen K, et al. Among authors: xu j. Oncotarget. 2017 Jul 11;8(28):46381-46389. doi: 10.18632/oncotarget.18453. Oncotarget. 2017. PMID: 28637026 Free PMC article.

6

Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection.

Qi ML, Guo YL, Wang QQ, Chen XS, Han JD, Su XH, Lun WH, Cheng H, Xu JH, Tian HQ, Chen L, Yao ZY, Feng WL, Jiang J, Zhou PY, Zou XB, Xu HH, Shi WM, Liu J, Zhu L, Liu QZ. Qi ML, et al. Among authors: xu jh, xu hh. Chin Med J (Engl). 2017 Dec 5;130(23):2852-2856. doi: 10.4103/0366-6999.219159. Chin Med J (Engl). 2017. PMID: 29176144 Free PMC article. No abstract available.

7

The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis.

Yan K, Han L, Deng H, Fang X, Zhang Z, Huang G, Zheng ZZ, Huang Q, Xu J. Yan K, et al. Among authors: xu j. J Dermatol Sci. 2018 Oct;92(1):106-113. doi: 10.1016/j.jdermsci.2018.07.001. Epub 2018 Jul 7. J Dermatol Sci. 2018. PMID: 30072243

8

Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.

Yan K, Zhang Y, Han L, Huang Q, Zhang Z, Fang X, Zheng Z, Yawalkar N, Chang Y, Zhang Q, Jin L, Qian D, Li X, Wu M, Xu Q, Zhang X, Xu J. Yan K, et al. Among authors: xu q, xu j. JAMA Dermatol. 2019 Mar 1;155(3):327-334. doi: 10.1001/jamadermatol.2018.5194. JAMA Dermatol. 2019. PMID: 30698628 Free PMC article.

9

Efficacy and safety of Run Zao Zhi Yang capsule on chronic eczema: a multiple-center, randomized, double-blind, placebo-controlled clinical study.

Huang D, Chen K, Zhang FR, Yang S, Guo Q, Xu JH, Li H, Tan GZ, Yang BQ, Lu QJ, Zheng J, Li LF, Gu H. Huang D, et al. Among authors: xu jh. J Dermatolog Treat. 2019 Nov;30(7):677-684. doi: 10.1080/09546634.2019.1571267. Epub 2019 Jun 20. J Dermatolog Treat. 2019. PMID: 31218889 Clinical Trial.

10

Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial.

Liu LF, Chen JS, Gu J, Xu JH, Jin HZ, Pang XW, Wang G, Yu C, Song ZQ, Guo ZP, Li W, Lai W, Cui PG, Chen M, Fang H, Lyu CZ, Li YZ, Sun Q, Xie HF, Liu XM, Gao XH, Shi YL, Zhao NQ, Zhang W, Zheng M. Liu LF, et al. Among authors: xu jh. Arch Dermatol Res. 2020 Aug;312(6):437-445. doi: 10.1007/s00403-019-02024-6. Epub 2019 Dec 23. Arch Dermatol Res. 2020. PMID: 31873772 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62,272 results

Search Page